Latest Blog: 18th January 2022
Regenerative medicine – A phenomenal year for new therapies and distributed manufacturing
Today marks a new milestone for cell and gene therapy pioneer Ori Biotech , as the company unveils an oversubscribed $100 million Series B funding round led by Novalis LifeSciences, increasing the total capital raised since inception two years ago to $140m. The raise will fuel market launch of the Ori system, a full stack, [...]
Blog: 26th February 2021
Finding Future Champions in UK Fintech
Blog: 18th December 2020
V7 Labs – MLOps For Vision AI
Blog: 27th August 2020
Transforming Care Delivery
Blog: 28th July 2020
As lockdown lifts – an update from Amadeus
Blog: 22nd July 2020
Early Bird Gets The Worm
Blog: 14th April 2020
CEO Update – Three weeks into lockdown